Cover Image
Market Research Report
Product code 
1077875

Over The Counter (OTC) Drugs Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027

Published: | IMARC Services Private Limited | 145 Pages | Delivery time: 2-3 business days

Price

Back to Top
Over The Counter (OTC) Drugs Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027
Published: May 18, 2022
IMARC Services Private Limited
Content info: 145 Pages
Delivery time: 2-3 business days
  • Description
  • Table of Contents
  • List of Tables

The global over the counter (OTC) drugs market reached a value of US$ 148 Billion in 2021. Looking forward, IMARC Group expects the market to reach a value of US$ 212.6 Billion by 2027, exhibiting a CAGR of 6.44% during 2022-2027. Keeping in mind the uncertainties of COVID-19, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic. These insights are included in the report as a major market contributor.

Over the counter (OTC) drugs, also known as non-prescription drugs, can be used without a prescription or the need for seeking treatment by a healthcare professional. They are safe and effective and help cure pain, cough and cold, diarrhea, constipation, acne and manage recurring migraines and allergies. They are currently available in pharmacies, convenience stores, supermarkets and gas stations across the globe.

Over The Counter (OTC) Drugs Market Trends:

  • The increasing utilization of OTC drugs to treat minor ailments among individuals represents one of the key factors bolstering the market growth. Besides this, OTC medications, such as antacids, histamine-2 (H2) blockers, and proton pump inhibitors (PPIs), are used to relieve and prevent heartburn or acid indigestion. In addition, due to the coronavirus disease (COVID-19) outbreak, there is a rise in awareness among individuals about the importance of self-care. This, in turn, is increasing the sales of nutritional supplements and strengthening the market growth. Moreover, key players are expanding their product portfolio to widen their consumer base and increase their geographical presence. This, coupled with the increasing approvals from regulatory bodies for switching prescription drugs to OTC drugs, is positively influencing the market. Apart from this, there is currently an increase in the number of people opting for OTC drugs rather than consulting physicians on account of increasing healthcare costs. Furthermore, self-medication practices can assist in controlling chronic diseases, reducing absenteeism from work, and saving scarce medical resources from being exhausted during minor conditions. Some of the other factors, such as the rising geriatric population worldwide, rapid expansion of distribution channels, and significant growth in the pharmaceutical industry, are driving the overall sales and profitability.

Key Market Segmentation:

  • IMARC Group provides an analysis of the key trends in each sub-segment of the global over the counter (OTC) drugs market, along with forecasts at the global, regional and country level from 2022-2027. Our report has categorized the market based on product type, route of administration, dosage form and distribution channel.

Breakup by Product Type:

  • Cough, Cold and Flu Products
  • Analgesics
  • Dermatology Products
  • Gastrointestinal Products
  • Vitamins, Minerals and Supplements (VMS)
  • Weight-loss/Dietary Products
  • Ophthalmic Products
  • Sleeping Aids
  • Others

Breakup by Route of Administration:

  • Oral
  • Parenteral
  • Topical
  • Others

Breakup by Dosage Form:

  • Tablets and Capsules
  • Liquids
  • Ointments
  • Others

Breakup by Distribution Channel:

  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies
  • Others

Breakup by Region:

  • North America
  • United States
  • Canada
  • Asia-Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Indonesia
  • Others
  • Europe
  • Germany
  • France
  • United Kingdom
  • Italy
  • Spain
  • Russia
  • Others
  • Latin America
  • Brazil
  • Mexico
  • Others
  • Middle East and Africa

Competitive Landscape:

  • The competitive landscape of the industry has also been examined along with the profiles of the key players being Alkem Laboratories Limited, Bayer AG, Daiichi Sankyo Company Limited, Dr. Reddy's Laboratories Ltd., GlaxoSmithKline plc, Johnson & Johnson, Novartis AG, Perrigo Company plc, Pfizer Inc., Piramal Enterprises Ltd., Reckitt Benckiser Group PLC, Sanofi S.A., Sun Pharmaceutical Industries Ltd. and Teva Pharmaceutical Industries Ltd.
  • Key Questions Answered in This Report
  • 1. What was the size of the global over the counter (OTC) drugs market in 2021?
  • 2. What is the expected growth rate of the global over the counter (OTC) drugs market during 2022-2027?
  • 3. What are the key factors driving the global over the counter (OTC) drugs market?
  • 4. What has been the impact of COVID-19 on the global over the counter (OTC) drugs market?
  • 5. What is the breakup of the global over the counter (OTC) drugs market based on the product type?
  • 6. What is the breakup of the global over the counter (OTC) drugs market based on the route of administration?
  • 7. What is the breakup of the global over the counter (OTC) drugs market based on the dosage form?
  • 8. What is the breakup of the global over the counter (OTC) drugs market based on the distribution channel?
  • 9. What are the key regions in the global over the counter (OTC) drugs market?
  • 10. Who are the key players/companies in the global over the counter (OTC) drugs market?
Product Code: SR0522A244_Report

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Over The Counter (OTC) Drugs Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Product Type

  • 6.1 Cough, Cold and Flu Products
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Analgesics
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast
  • 6.3 Dermatology Products
    • 6.3.1 Market Trends
    • 6.3.2 Market Forecast
  • 6.4 Gastrointestinal Products
    • 6.4.1 Market Trends
    • 6.4.2 Market Forecast
  • 6.5 Vitamins, Minerals and Supplements (VMS)
    • 6.5.1 Market Trends
    • 6.5.2 Market Forecast
  • 6.6 Weight-loss/Dietary Products
    • 6.6.1 Market Trends
    • 6.6.2 Market Forecast
  • 6.7 Ophthalmic Products
    • 6.7.1 Market Trends
    • 6.7.2 Market Forecast
  • 6.8 Sleeping Aids
    • 6.8.1 Market Trends
    • 6.8.2 Market Forecast
  • 6.9 Others
    • 6.9.1 Market Trends
    • 6.9.2 Market Forecast

7 Market Breakup by Route of Administration

  • 7.1 Oral
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Parenteral
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Topical
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast
  • 7.4 Others
    • 7.4.1 Market Trends
    • 7.4.2 Market Forecast

8 Market Breakup by Dosage Form

  • 8.1 Tablets and Capsules
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Liquids
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Ointments
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast
  • 8.4 Others
    • 8.4.1 Market Trends
    • 8.4.2 Market Forecast

9 Market Breakup by Distribution Channel

  • 9.1 Hospital Pharmacies
    • 9.1.1 Market Trends
    • 9.1.2 Market Forecast
  • 9.2 Retail Pharmacies
    • 9.2.1 Market Trends
    • 9.2.2 Market Forecast
  • 9.3 Online Pharmacies
    • 9.3.1 Market Trends
    • 9.3.2 Market Forecast
  • 9.4 Others
    • 9.4.1 Market Trends
    • 9.4.2 Market Forecast

10 Market Breakup by Region

  • 10.1 North America
    • 10.1.1 United States
      • 10.1.1.1 Market Trends
      • 10.1.1.2 Market Forecast
    • 10.1.2 Canada
      • 10.1.2.1 Market Trends
      • 10.1.2.2 Market Forecast
  • 10.2 Asia-Pacific
    • 10.2.1 China
      • 10.2.1.1 Market Trends
      • 10.2.1.2 Market Forecast
    • 10.2.2 Japan
      • 10.2.2.1 Market Trends
      • 10.2.2.2 Market Forecast
    • 10.2.3 India
      • 10.2.3.1 Market Trends
      • 10.2.3.2 Market Forecast
    • 10.2.4 South Korea
      • 10.2.4.1 Market Trends
      • 10.2.4.2 Market Forecast
    • 10.2.5 Australia
      • 10.2.5.1 Market Trends
      • 10.2.5.2 Market Forecast
    • 10.2.6 Indonesia
      • 10.2.6.1 Market Trends
      • 10.2.6.2 Market Forecast
    • 10.2.7 Others
      • 10.2.7.1 Market Trends
      • 10.2.7.2 Market Forecast
  • 10.3 Europe
    • 10.3.1 Germany
      • 10.3.1.1 Market Trends
      • 10.3.1.2 Market Forecast
    • 10.3.2 France
      • 10.3.2.1 Market Trends
      • 10.3.2.2 Market Forecast
    • 10.3.3 United Kingdom
      • 10.3.3.1 Market Trends
      • 10.3.3.2 Market Forecast
    • 10.3.4 Italy
      • 10.3.4.1 Market Trends
      • 10.3.4.2 Market Forecast
    • 10.3.5 Spain
      • 10.3.5.1 Market Trends
      • 10.3.5.2 Market Forecast
    • 10.3.6 Russia
      • 10.3.6.1 Market Trends
      • 10.3.6.2 Market Forecast
    • 10.3.7 Others
      • 10.3.7.1 Market Trends
      • 10.3.7.2 Market Forecast
  • 10.4 Latin America
    • 10.4.1 Brazil
      • 10.4.1.1 Market Trends
      • 10.4.1.2 Market Forecast
    • 10.4.2 Mexico
      • 10.4.2.1 Market Trends
      • 10.4.2.2 Market Forecast
    • 10.4.3 Others
      • 10.4.3.1 Market Trends
      • 10.4.3.2 Market Forecast
  • 10.5 Middle East and Africa
    • 10.5.1 Market Trends
    • 10.5.2 Market Breakup by Country
    • 10.5.3 Market Forecast

11 SWOT Analysis

  • 11.1 Overview
  • 11.2 Strengths
  • 11.3 Weaknesses
  • 11.4 Opportunities
  • 11.5 Threats

12 Value Chain Analysis

13 Porters Five Forces Analysis

  • 13.1 Overview
  • 13.2 Bargaining Power of Buyers
  • 13.3 Bargaining Power of Suppliers
  • 13.4 Degree of Competition
  • 13.5 Threat of New Entrants
  • 13.6 Threat of Substitutes

14 Price Analysis

15 Competitive Landscape

  • 15.1 Market Structure
  • 15.2 Key Players
  • 15.3 Profiles of Key Players
    • 15.3.1 Alkem Laboratories Limited
      • 15.3.1.1 Company Overview
      • 15.3.1.2 Product Portfolio
      • 15.3.1.3 Financials
      • 15.3.1.4 SWOT Analysis
    • 15.3.2 Bayer AG
      • 15.3.2.1 Company Overview
      • 15.3.2.2 Product Portfolio
      • 15.3.2.3 Financials
      • 15.3.2.4 SWOT Analysis
    • 15.3.3 Daiichi Sankyo Company Limited
      • 15.3.3.1 Company Overview
      • 15.3.3.2 Product Portfolio
      • 15.3.3.3 Financials
      • 15.3.3.4 SWOT Analysis
    • 15.3.4 Dr. Reddy's Laboratories Ltd.
      • 15.3.4.1 Company Overview
      • 15.3.4.2 Product Portfolio
      • 15.3.4.3 Financials
      • 15.3.4.4 SWOT Analysis
    • 15.3.5 GlaxoSmithKline plc
      • 15.3.5.1 Company Overview
      • 15.3.5.2 Product Portfolio
      • 15.3.5.3 Financials
      • 15.3.5.4 SWOT Analysis
    • 15.3.6 Johnson & Johnson
      • 15.3.6.1 Company Overview
      • 15.3.6.2 Product Portfolio
      • 15.3.6.3 Financials
      • 15.3.6.4 SWOT Analysis
    • 15.3.7 Novartis AG
      • 15.3.7.1 Company Overview
      • 15.3.7.2 Product Portfolio
      • 15.3.7.3 Financials
      • 15.3.7.4 SWOT Analysis
    • 15.3.8 Perrigo Company plc
      • 15.3.8.1 Company Overview
      • 15.3.8.2 Product Portfolio
      • 15.3.8.3 Financials
      • 15.3.8.4 SWOT Analysis
    • 15.3.9 Pfizer Inc.
      • 15.3.9.1 Company Overview
      • 15.3.9.2 Product Portfolio
      • 15.3.9.3 Financials
      • 15.3.9.4 SWOT Analysis
    • 15.3.10 Piramal Enterprises Ltd.
      • 15.3.10.1 Company Overview
      • 15.3.10.2 Product Portfolio
      • 15.3.10.3 Financials
    • 15.3.11 Reckitt Benckiser Group PLC
      • 15.3.11.1 Company Overview
      • 15.3.11.2 Product Portfolio
      • 15.3.11.3 Financials
      • 15.3.11.4 SWOT Analysis
    • 15.3.12 Sanofi S.A.
      • 15.3.12.1 Company Overview
      • 15.3.12.2 Product Portfolio
      • 15.3.12.3 Financials
      • 15.3.12.4 SWOT Analysis
    • 15.3.13 Sun Pharmaceutical Industries Ltd.
      • 15.3.13.1 Company Overview
      • 15.3.13.2 Product Portfolio
      • 15.3.13.3 Financials
      • 15.3.13.4 SWOT Analysis
    • 15.3.14 Teva Pharmaceutical Industries Ltd.
      • 15.3.14.1 Company Overview
      • 15.3.14.2 Product Portfolio
      • 15.3.14.3 Financials
      • 15.3.14.4 SWOT Analysis

List of Figures

  • Figure 1: Global: Over The Counter Drugs Market: Major Drivers and Challenges
  • Figure 2: Global: Over The Counter Drugs Market: Sales Value (in Billion US$), 2016-2021
  • Figure 3: Global: Over The Counter Drugs Market Forecast: Sales Value (in Billion US$), 2022-2027
  • Figure 4: Global: Over The Counter Drugs Market: Breakup by Product Type (in %), 2021
  • Figure 5: Global: Over The Counter Drugs Market: Breakup by Route of Administration (in %), 2021
  • Figure 6: Global: Over The Counter Drugs Market: Breakup by Dosage Form (in %), 2021
  • Figure 7: Global: Over The Counter Drugs Market: Breakup by Distribution Channel (in %), 2021
  • Figure 8: Global: Over The Counter Drugs Market: Breakup by Region (in %), 2021
  • Figure 9: Global: Over The Counter Drugs (Cough, Cold and Flu Products) Market: Sales Value (in Million US$), 2016 & 2021
  • Figure 10: Global: Over The Counter Drugs (Cough, Cold and Flu Products) Market Forecast: Sales Value (in Million US$), 2022-2027
  • Figure 11: Global: Over The Counter Drugs (Analgesics) Market: Sales Value (in Million US$), 2016 & 2021
  • Figure 12: Global: Over The Counter Drugs (Analgesics) Market Forecast: Sales Value (in Million US$), 2022-2027
  • Figure 13: Global: Over The Counter Drugs (Dermatology Products) Market: Sales Value (in Million US$), 2016 & 2021
  • Figure 14: Global: Over The Counter Drugs (Dermatology Products) Market Forecast: Sales Value (in Million US$), 2022-2027
  • Figure 15: Global: Over The Counter Drugs (Gastrointestinal Products) Market: Sales Value (in Million US$), 2016 & 2021
  • Figure 16: Global: Over The Counter Drugs (Gastrointestinal Products) Market Forecast: Sales Value (in Million US$), 2022-2027
  • Figure 17: Global: Over The Counter Drugs (Vitamins, Minerals and Supplements (VMS)) Market: Sales Value (in Million US$), 2016 & 2021
  • Figure 18: Global: Over The Counter Drugs (Vitamins, Minerals and Supplements (VMS)) Market Forecast: Sales Value (in Million US$), 2022-2027
  • Figure 19: Global: Over The Counter Drugs (Weight-loss/Dietary Products) Market: Sales Value (in Million US$), 2016 & 2021
  • Figure 20: Global: Over The Counter Drugs (Weight-loss/Dietary Products) Market Forecast: Sales Value (in Million US$), 2022-2027
  • Figure 21: Global: Over The Counter Drugs (Ophthalmic Products) Market: Sales Value (in Million US$), 2016 & 2021
  • Figure 22: Global: Over The Counter Drugs (Ophthalmic Products) Market Forecast: Sales Value (in Million US$), 2022-2027
  • Figure 23: Global: Over The Counter Drugs (Sleeping Aids) Market: Sales Value (in Million US$), 2016 & 2021
  • Figure 24: Global: Over The Counter Drugs (Sleeping Aids) Market Forecast: Sales Value (in Million US$), 2022-2027
  • Figure 25: Global: Over The Counter Drugs (Other Product Types) Market: Sales Value (in Million US$), 2016 & 2021
  • Figure 26: Global: Over The Counter Drugs (Other Product Types) Market Forecast: Sales Value (in Million US$), 2022-2027
  • Figure 27: Global: Over The Counter Drugs (Oral) Market: Sales Value (in Million US$), 2016 & 2021
  • Figure 28: Global: Over The Counter Drugs (Oral) Market Forecast: Sales Value (in Million US$), 2022-2027
  • Figure 29: Global: Over The Counter Drugs (Parenteral) Market: Sales Value (in Million US$), 2016 & 2021
  • Figure 30: Global: Over The Counter Drugs (Parenteral) Market Forecast: Sales Value (in Million US$), 2022-2027
  • Figure 31: Global: Over The Counter Drugs (Topical) Market: Sales Value (in Million US$), 2016 & 2021
  • Figure 32: Global: Over The Counter Drugs (Topical) Market Forecast: Sales Value (in Million US$), 2022-2027
  • Figure 33: Global: Over The Counter Drugs (Other Route of Administrations) Market: Sales Value (in Million US$), 2016 & 2021
  • Figure 34: Global: Over The Counter Drugs (Other Route of Administrations) Market Forecast: Sales Value (in Million US$), 2022-2027
  • Figure 35: Global: Over The Counter Drugs (Tablets and Capsules) Market: Sales Value (in Million US$), 2016 & 2021
  • Figure 36: Global: Over The Counter Drugs (Tablets and Capsules) Market Forecast: Sales Value (in Million US$), 2022-2027
  • Figure 37: Global: Over The Counter Drugs (Liquids) Market: Sales Value (in Million US$), 2016 & 2021
  • Figure 38: Global: Over The Counter Drugs (Liquids) Market Forecast: Sales Value (in Million US$), 2022-2027
  • Figure 39: Global: Over The Counter Drugs (Ointments) Market: Sales Value (in Million US$), 2016 & 2021
  • Figure 40: Global: Over The Counter Drugs (Ointments) Market Forecast: Sales Value (in Million US$), 2022-2027
  • Figure 41: Global: Over The Counter Drugs (Other Dosage Forms) Market: Sales Value (in Million US$), 2016 & 2021
  • Figure 42: Global: Over The Counter Drugs (Other Dosage Forms) Market Forecast: Sales Value (in Million US$), 2022-2027
  • Figure 43: Global: Over The Counter Drugs (Hospital Pharmacies) Market: Sales Value (in Million US$), 2016 & 2021
  • Figure 44: Global: Over The Counter Drugs (Hospital Pharmacies) Market Forecast: Sales Value (in Million US$), 2022-2027
  • Figure 45: Global: Over The Counter Drugs (Retail Pharmacies) Market: Sales Value (in Million US$), 2016 & 2021
  • Figure 46: Global: Over The Counter Drugs (Retail Pharmacies) Market Forecast: Sales Value (in Million US$), 2022-2027
  • Figure 47: Global: Over The Counter Drugs (Online Pharmacies) Market: Sales Value (in Million US$), 2016 & 2021
  • Figure 48: Global: Over The Counter Drugs (Online Pharmacies) Market Forecast: Sales Value (in Million US$), 2022-2027
  • Figure 49: Global: Over The Counter Drugs (Other Distribution Channels) Market: Sales Value (in Million US$), 2016 & 2021
  • Figure 50: Global: Over The Counter Drugs (Other Distribution Channels) Market Forecast: Sales Value (in Million US$), 2022-2027
  • Figure 51: North America: Over The Counter Drugs Market: Sales Value (in Million US$), 2016 & 2021
  • Figure 52: North America: Over The Counter Drugs Market Forecast: Sales Value (in Million US$), 2022-2027
  • Figure 53: United States: Over The Counter Drugs Market: Sales Value (in Million US$), 2016 & 2021
  • Figure 54: United States: Over The Counter Drugs Market Forecast: Sales Value (in Million US$), 2022-2027
  • Figure 55: Canada: Over The Counter Drugs Market: Sales Value (in Million US$), 2016 & 2021
  • Figure 56: Canada: Over The Counter Drugs Market Forecast: Sales Value (in Million US$), 2022-2027
  • Figure 57: Asia-Pacific: Over The Counter Drugs Market: Sales Value (in Million US$), 2016 & 2021
  • Figure 58: Asia-Pacific: Over The Counter Drugs Market Forecast: Sales Value (in Million US$), 2022-2027
  • Figure 59: China: Over The Counter Drugs Market: Sales Value (in Million US$), 2016 & 2021
  • Figure 60: China: Over The Counter Drugs Market Forecast: Sales Value (in Million US$), 2022-2027
  • Figure 61: Japan: Over The Counter Drugs Market: Sales Value (in Million US$), 2016 & 2021
  • Figure 62: Japan: Over The Counter Drugs Market Forecast: Sales Value (in Million US$), 2022-2027
  • Figure 63: India: Over The Counter Drugs Market: Sales Value (in Million US$), 2016 & 2021
  • Figure 64: India: Over The Counter Drugs Market Forecast: Sales Value (in Million US$), 2022-2027
  • Figure 65: South Korea: Over The Counter Drugs Market: Sales Value (in Million US$), 2016 & 2021
  • Figure 66: South Korea: Over The Counter Drugs Market Forecast: Sales Value (in Million US$), 2022-2027
  • Figure 67: Australia: Over The Counter Drugs Market: Sales Value (in Million US$), 2016 & 2021
  • Figure 68: Australia: Over The Counter Drugs Market Forecast: Sales Value (in Million US$), 2022-2027
  • Figure 69: Indonesia: Over The Counter Drugs Market: Sales Value (in Million US$), 2016 & 2021
  • Figure 70: Indonesia: Over The Counter Drugs Market Forecast: Sales Value (in Million US$), 2022-2027
  • Figure 71: Others: Over The Counter Drugs Market: Sales Value (in Million US$), 2016 & 2021
  • Figure 72: Others: Over The Counter Drugs Market Forecast: Sales Value (in Million US$), 2022-2027
  • Figure 73: Europe: Over The Counter Drugs Market: Sales Value (in Million US$), 2016 & 2021
  • Figure 74: Europe: Over The Counter Drugs Market Forecast: Sales Value (in Million US$), 2022-2027
  • Figure 75: Germany: Over The Counter Drugs Market: Sales Value (in Million US$), 2016 & 2021
  • Figure 76: Germany: Over The Counter Drugs Market Forecast: Sales Value (in Million US$), 2022-2027
  • Figure 77: France: Over The Counter Drugs Market: Sales Value (in Million US$), 2016 & 2021
  • Figure 78: France: Over The Counter Drugs Market Forecast: Sales Value (in Million US$), 2022-2027
  • Figure 79: United Kingdom: Over The Counter Drugs Market: Sales Value (in Million US$), 2016 & 2021
  • Figure 80: United Kingdom: Over The Counter Drugs Market Forecast: Sales Value (in Million US$), 2022-2027
  • Figure 81: Italy: Over The Counter Drugs Market: Sales Value (in Million US$), 2016 & 2021
  • Figure 82: Italy: Over The Counter Drugs Market Forecast: Sales Value (in Million US$), 2022-2027
  • Figure 83: Spain: Over The Counter Drugs Market: Sales Value (in Million US$), 2016 & 2021
  • Figure 84: Spain: Over The Counter Drugs Market Forecast: Sales Value (in Million US$), 2022-2027
  • Figure 85: Russia: Over The Counter Drugs Market: Sales Value (in Million US$), 2016 & 2021
  • Figure 86: Russia: Over The Counter Drugs Market Forecast: Sales Value (in Million US$), 2022-2027
  • Figure 87: Others: Over The Counter Drugs Market: Sales Value (in Million US$), 2016 & 2021
  • Figure 88: Others: Over The Counter Drugs Market Forecast: Sales Value (in Million US$), 2022-2027
  • Figure 89: Latin America: Over The Counter Drugs Market: Sales Value (in Million US$), 2016 & 2021
  • Figure 90: Latin America: Over The Counter Drugs Market Forecast: Sales Value (in Million US$), 2022-2027
  • Figure 91: Brazil: Over The Counter Drugs Market: Sales Value (in Million US$), 2016 & 2021
  • Figure 92: Brazil: Over The Counter Drugs Market Forecast: Sales Value (in Million US$), 2022-2027
  • Figure 93: Mexico: Over The Counter Drugs Market: Sales Value (in Million US$), 2016 & 2021
  • Figure 94: Mexico: Over The Counter Drugs Market Forecast: Sales Value (in Million US$), 2022-2027
  • Figure 95: Others: Over The Counter Drugs Market: Sales Value (in Million US$), 2016 & 2021
  • Figure 96: Others: Over The Counter Drugs Market Forecast: Sales Value (in Million US$), 2022-2027
  • Figure 97: Middle East and Africa: Over The Counter Drugs Market: Sales Value (in Million US$), 2016 & 2021
  • Figure 98: Middle East and Africa: Over The Counter Drugs Market: Breakup by Country (in %), 2021
  • Figure 99: Middle East and Africa: Over The Counter Drugs Market Forecast: Sales Value (in Million US$), 2022-2027
  • Figure 100: Global: Over The Counter Drugs Industry: SWOT Analysis
  • Figure 101: Global: Over The Counter Drugs Industry: Value Chain Analysis
  • Figure 102: Global: Over The Counter Drugs Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Over The Counter Drugs Market: Key Industry Highlights, 2021 and 2027
  • Table 2: Global: Over The Counter Drugs Market Forecast: Breakup by Product Type (in Million US$), 2022-2027
  • Table 3: Global: Over The Counter Drugs Market Forecast: Breakup by Route of Administration (in Million US$), 2022-2027
  • Table 4: Global: Over The Counter Drugs Market Forecast: Breakup by Dosage Form (in Million US$), 2022-2027
  • Table 5: Global: Over The Counter Drugs Market Forecast: Breakup by Distribution Channel (in Million US$), 2022-2027
  • Table 6: Global: Over The Counter Drugs Market Forecast: Breakup by Region (in Million US$), 2022-2027
  • Table 7: Global: Over The Counter Drugs Market: Competitive Structure
  • Table 8: Global: Over The Counter Drugs Market: Key Players